Head of Life Science Division @ Kinetica | North America, Europe & APAC Recruitment Solutions | 13,000+ Followers
Olink Proteomics Shares Take a Hit as German Regulators Intensify Scrutiny of Pending Acquisition by Thermo Fisher. the proteomics firm, saw a significant decline of over 8 percent in its shares during Tuesday's afternoon trading on the Nasdaq. This drop came after the company revealed that German regulators are delving deeper into its proposed $3.1 billion acquisition by Thermo Fisher Scientific. In a disclosure to the US Securities and Exchange Commission on Tuesday, Olink stated that the German Bundeskartellamt, the country's competition regulatory body, has informed Thermo Fisher of its initiation of a Phase 2 review regarding the pending acquisition. What might be the potential implications of the German Bundeskartellamt's Phase 2 review on Olink's acquisition by Thermo Fisher Scientific? #proteomics #acquistion #phase2 #olink #thermo